Page 2 - புற்றுநோயியல் இல் உணர்ச்சி பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புற்றுநோயியல் இல் உணர்ச்சி பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புற்றுநோயியல் இல் உணர்ச்சி பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து Today - Breaking & Trending Today

Synthetic microRNA can serve as a novel therapeutic agent for treating human cancer

Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic ....

Michel Janicot , Emily Henderson , Oncotarget Research Output , Janicot Research Team , Cell Cycle , Cell Proliferation , Dna Damage , Ene Expression , N Vivo , எமிலி ஹென்டர்சன் ,

Oncology Pharma Inc.: Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange


(0)
SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) has submitted its initial application to the NASDAQ to begin the process of moving the listing from the Pink Sheets to the Capital Markets Tier of the NASDAQ Exchange. The Company, its Board, advisors and management team are going to devote resources to accomplish this as swiftly as possible. We are delighted to have submitted the initial application and will work through the process utilizing all resources to our disposal.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the Company ) is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare. ....

San Francisco , United States , Kostenloser Wertpapierhandel , Oncology Pharma Inc , Oncology Pharma , Pink Sheets , Capital Markets Tier , Advisory Board , Sansome Street , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோயியல் பார்மா இன்க் , புற்றுநோயியல் பார்மா , இளஞ்சிவப்பு தாள்கள் ,